Literature DB >> 32699134

Spatial Density and Distribution of Tumor-Associated Macrophages Predict Survival in Non-Small Cell Lung Carcinoma.

Xiang Zheng1, Andreas Weigert2, Simone Reu3, Stefan Guenther1, Siavash Mansouri1, Birgit Bassaly4, Stefan Gattenlöhner4, Friedrich Grimminger5, Soni Pullamsetti1,5, Werner Seeger1,5,6, Hauke Winter7, Rajkumar Savai8,5,6,9.   

Abstract

The respective antitumoral and protumoral roles of M1 and M2 tumor-associated macrophages (TAM) typify the complexity of macrophage function in cancer. In lung cancer, density and topology of distinct TAM phenotypes at the tumor center (TC) versus the invasive margin (IM) are largely unknown. Here, we investigated TAM subtype density and distribution between TC and IM in human lung cancer and TAM associations with overall survival. Macrophages isolated from adjacent nontumor tissue (NM), the TC (TC-TAM), and the IM (IM-TAM) were analyzed with RNA-sequencing (RNA-seq). Lung tumor tissue microarrays from 104 patient samples were constructed. M1 and M2 TAMs were identified using multiplex immunofluorescence staining and a tumor cell-TAM proximity analysis was performed. RNA-seq identified marked differences among NM, TC-TAM, and IM-TAM. On the basis of a panel of five selected markers (CD68, IL12, CCR7, CD163, and ALOX15), M2 predominance over M1 and M2 proximity to tumor cells was observed, especially at IM. Tumor cell proximity to TAM was linked with tumor cell survival and hypoxia was associated with accumulation of M2 TAM. Notably, lower density of M1 TC-TAM and higher proximity of tumor cells to M2 IM-TAM or lower proximity to M1 IM-TAM were linked with poor survival. In addition, three novel molecules (UBXN4, MFSD12, and ACTR6) from RNA-seq served as potential prognostic markers for lung cancer, and M2 predominance and juxtaposition of M2 TAM near tumor cells were associated with poor survival. Together, our results reveal the marked heterogeneity of TAM populations in different tumor regions, with M2 TAM predominance, particularly at IM. SIGNIFICANCE: This study underlines the significance of the density, spatial distribution, and gene expression of TAM phenotypes as prognostic factors for overall survival in lung cancer. GRAPHICAL ABSTRACT: http://cancerres.aacrjournals.org/content/canres/80/20/4414/F1.large.jpg. ©2020 American Association for Cancer Research.

Entities:  

Year:  2020        PMID: 32699134     DOI: 10.1158/0008-5472.CAN-20-0069

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  31 in total

1.  Quantitative assessment of intratumoral 2-[18F]FDG metabolic spatial distribution in hypermetabolic pulmonary lesions in PET/CT.

Authors:  Ling Wang; Jia Jiang; Beihui Xue; Jie Lin; Xiaowei Ji; Xiangwu Zheng; Kun Tang
Journal:  Quant Imaging Med Surg       Date:  2022-07

2.  Spatial UMAP and Image Cytometry for Topographic Immuno-oncology Biomarker Discovery.

Authors:  Alexander S Baras; Janis M Taube; Nicolas A Giraldo; Sneha Berry; Etienne Becht; Deniz Ates; Kara M Schenk; Elizabeth L Engle; Benjamin Green; Peter Nguyen; Abha Soni; Julie E Stein; Farah Succaria; Aleksandra Ogurtsova; Haiying Xu; Raphael Gottardo; Robert A Anders; Evan J Lipson; Ludmila Danilova
Journal:  Cancer Immunol Res       Date:  2021-08-25       Impact factor: 12.020

3.  Association of Clonal Hematopoiesis of Indeterminate Potential with Inflammatory Gene Expression in Patients with COPD.

Authors:  Stefan Kuhnert; Siavash Mansouri; Michael A Rieger; Rajkumar Savai; Edibe Avci; Gabriela Díaz-Piña; Manju Padmasekar; Mario Looso; Stefan Hadzic; Till Acker; Stephan Klatt; Jochen Wilhelm; Ingrid Fleming; Natascha Sommer; Norbert Weissmann; Claus Vogelmeier; Robert Bals; Andreas Zeiher; Stefanie Dimmeler; Werner Seeger; Soni S Pullamsetti
Journal:  Cells       Date:  2022-07-05       Impact factor: 7.666

4.  Metabolism in tumor-associated macrophages.

Authors:  Jie Li; Gina M DeNicola; Brian Ruffell
Journal:  Int Rev Cell Mol Biol       Date:  2022-02-21       Impact factor: 6.420

5.  Dysregulation of circulating CDC42 and its correlation with demographic characteristics, comorbidities, tumor features, chemotherapeutic regimen and survival profile in non-small-cell lung cancer patients.

Authors:  Jie Yan; Daihong Wan
Journal:  J Clin Lab Anal       Date:  2021-12-24       Impact factor: 2.352

Review 6.  Is the C-C Motif Ligand 2-C-C Chemokine Receptor 2 Axis a Promising Target for Cancer Therapy and Diagnosis?

Authors:  Hiroaki Iwamoto; Kouji Izumi; Atsushi Mizokami
Journal:  Int J Mol Sci       Date:  2020-12-07       Impact factor: 5.923

Review 7.  Cancer-Associated Fibroblasts and Tumor-Associated Macrophages in Cancer and Cancer Immunotherapy.

Authors:  Hans Raskov; Adile Orhan; Shruti Gaggar; Ismail Gögenur
Journal:  Front Oncol       Date:  2021-05-20       Impact factor: 6.244

8.  Artificial intelligence-based analysis for immunohistochemistry staining of immune checkpoints to predict resected non-small cell lung cancer survival and relapse.

Authors:  Haoyue Guo; Li Diao; Xiaofeng Zhou; Jie-Neng Chen; Yue Zhou; Qiyu Fang; Yayi He; Rafal Dziadziuszko; Caicun Zhou; Fred R Hirsch
Journal:  Transl Lung Cancer Res       Date:  2021-06

Review 9.  Methods to Determine and Analyze the Cellular Spatial Distribution Extracted From Multiplex Immunofluorescence Data to Understand the Tumor Microenvironment.

Authors:  Edwin Roger Parra
Journal:  Front Mol Biosci       Date:  2021-06-14

10.  Multi-institutional TSA-amplified Multiplexed Immunofluorescence Reproducibility Evaluation (MITRE) Study.

Authors:  Janis M Taube; Kristin Roman; Elizabeth L Engle; Chichung Wang; Carmen Ballesteros-Merino; Shawn M Jensen; John McGuire; Mei Jiang; Carla Coltharp; Bethany Remeniuk; Ignacio Wistuba; Darren Locke; Edwin R Parra; Bernard A Fox; David L Rimm; Cliff Hoyt
Journal:  J Immunother Cancer       Date:  2021-07       Impact factor: 13.751

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.